Therefore, we herein focused on the ‘initial survival’ of ALK-rearranged cancer cells treated with ALC and investigated the factors or pathways responsible for survival by evaluating the initial responses of ALK-rearranged cells to a treatment with ALC using a proteome approach with patient-derived cells. The gene discussed is ALK; the disease is cancer.